Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Management to Webcast Investor Day

WILMINGTON, Mass.--(BUSINESS WIRE)--May 24, 2004--Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Management will hold a meeting for the investment community on Wednesday, June 2, 2004. Investors as well as the general public are invited to listen to a live webcast of the meeting which is scheduled to begin at 8:30 a.m. and is expected to last until approximately 3:30 p.m. Eastern Daylight Time.

The live webcast of the meeting will be available through links that will be posted on the Investor Relations section of the Charles River Laboratories website, http://ir.criver.com. A webcast replay will be accessible through the same website approximately three hours after the meeting and will remain available until June 9, 2004.


    CONTACT: Charles River Laboratories International, Inc.
             Susan E. Hardy, 978-658-6000 ext. 1616

    SOURCE: Charles River Laboratories International, Inc.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)